HNL Lab Medicine has hired David M. Confalone as vice president of finance.
“HNL Lab Medicine is pleased to welcome David to our organization,” said Martin Till, HNL president & CEO. “He brings an engaged leadership style and collaborative approach with deep expertise in finance, human capital development, budgeting, and forecasting that will be invaluable as we continue to grow our company.”
Confalone joins the HNL team with over 30 years of experience. He has held senior and executive level finance positions with mid-to-large sized for-profit and non-profit organizations, having previously served as chief financial and operating officer at Advanced Dermatology Associates.
“I’m extremely excited to join such a dynamic, growing organization that is dedicated to caring for our community and improving patient health,” Confalone said. “HNL is uniquely positioned to capitalize on its vision using technology, innovation, and talent, and I look forward to being a part of its tremendous success!”
Confalone graduated from DeSales University with a degree in accounting and earned a Master of Business Administration from Alvernia University.